Total trials
77
Active
7
Phase 3
3
Total enrollment
445,015
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Colchicine | — | — | — | — | — | 1 |
Next readouts
- 2028-03-30
Top conditions
- Fecal Incontinence3
- Lumbar Disc Disease2
- Lumbar Spine Degeneration2
- Lumbar Spinal Stenosis2
- Rectal Cancer2
- Functional Outcome2
- Surgery2
- HIV Infections2
Frequently asked questions about Cantonal Hospital of St. Gallen
- How many clinical trials does Cantonal Hospital of St. Gallen have on ClinicalTrials.gov?
- Cantonal Hospital of St. Gallen is listed as the lead sponsor on 77 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Cantonal Hospital of St. Gallen's trials are in Phase 3?
- 3 of Cantonal Hospital of St. Gallen's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Cantonal Hospital of St. Gallen focus on?
- Cantonal Hospital of St. Gallen's most-studied conditions on ClinicalTrials.gov are Fecal Incontinence, Lumbar Disc Disease, Lumbar Spine Degeneration, Lumbar Spinal Stenosis, Rectal Cancer.
- When are Cantonal Hospital of St. Gallen's next clinical trial readouts?
- Cantonal Hospital of St. Gallen has 1 upcoming primary-completion readout tracked here; the soonest is “Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery”, expected around 2028-03-30.